Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2011

Conditions
Uterine FibroidsFertility Disorders
Interventions
OTHER

Ringer lactate solution

Ringer lactate solution was applied directly onto the uterine surgical sites at the end of the myomectomy surgery, to prevent post-surgical adhesion formation.

DEVICE

Prevadh film

Prevadh film was applied directly onto the uterine surgical sites at the end of the myomectomy surgery to prevent post-surgical adhesion formation.

Trial Locations (11)

30029

University Carémeau Hospital, Nîmes

33000

Clinique du Tondu, Bordeaux

35023

South University Hospital, Rennes

49933

University Hospital, Angers

63003

UNIVERSITY HOSPITAL Estaing, Clermont-Ferrand

75020

TENON Hospital (Public Assistance of Paris Hospital), Paris

75571

TROUSSEAU Hospital (Public Assistance of Paris Hospital), Paris

75877

Bichat Hospital - Claude Bernard (Public Assistance of Paris Hospital), Paris

78157

Versailles Hospital, Versailles

92141

Béclère Hospital (Public Assistance of Paris Hospital), Clamart

92317

Centre Hospitalier des quatre villes, Sèvres

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Registrat-Mapi

OTHER

lead

Medtronic - MITG

INDUSTRY